Experienced Principal Scientist with a demonstrated history of leading successful projects in the pharmaceuticals industry. My passion is solving problems and I have led teams and developed new methods and technology to address analytical challenges across both small and large molecule platforms. Currently, RNA therapeutics represent a transformational solution across a range of human disease. My years of experience in addressing those analytical problems ensures that timelines are met and patient solutions are provided in a fast and safe manner. Demonstrated track record of Analytical accomplishments including development of the Premier UPLC columns and LC system to address non-specific binding of oligonucleotides to metallic surfaces. Challenges in mRNA analysis led to development of improved ion pairing LC methods that can be easily implemented downstream. And challenges of drug delivery and lipid nanoparticles have led to improved methodology in support of formulation teams.